VERNON, BC – March 19, 2018 – True Leaf Medicine International Ltd., the quality of life cannabis company for people and their pets, has recruited two medicinal cannabis cultivation experts to lead the development of its medicinal cannabis products.
Stephen Schroeder, chief cannabis industry advisor, and Christian Zofchak, director of horticulture operations, have joined the True Leaf team, driven by a motivation to help patients, as well as their own family members, who find their pharmaceutical treatments ineffective or intolerable.
“True Leaf is assembling a world-class team of medical, genetics and cultivation experts,” said Darcy Bomford, founder and chief executive officer of True Leaf. “Our mission is to be Canada’s leading purpose-driven cannabis company, so we are proud to announce today Stephen and Christian will be creating high-quality medical products for people and their pets here at True Leaf Campus.”
The cultivation team members are Canadian leaders in selective cannabis plant development. They will identify the best cannabis plant genetics worldwide, and, as part of True Leaf’s proprietary intellectual property, will develop unique strains capable of producing the active ingredients needed to develop a highly-effective medicinal product line to address neurological, musculoskeletal, gynaecological and gastrointestinal conditions.
Mr. Schroeder has overseen millions of square feet of cannabis cultivation worldwide. Now an Okanagan Valley resident, he has consulted on cannabis operations in several European Union countries, throughout the United States, and in South America helping thousands of patients. His approach to cannabis horticulture emphasizes purity and precise control of all parameters of the growth cycle.
“I’ll be leading the careful genetic selection of stronger strains that will make people feel better,” said Mr. Schroeder. “I’ve designed techniques to preserve the whole plant medicine. This means we can use the full spectrum of therapeutic benefits cannabis has to offer. I’m excited to bring this and other specialized growing techniques to True Leaf.”
Mr. Zofchak, drawing on more than 20 years of experience, will provide the precise environmental controls necessary to eliminate the need for pesticides and fungicides during the production of cannabis products. The control of these conditions will enable the team to produce whole plant medicines and extractions.
“I am very proud to be part of a team that puts patients first with such a strong commitment to quality cannabis cultivation,” said Mr. Zofchak. “I believe that True Leaf will be one of the few licensed producers capable of providing consistent pharmaceutical grade cannabis and extractions. This is only possible with our scientific approach and dedication.”
True Leaf has received permission by Health Canada to build its True Leaf Campus cannabis cultivation facility and broke ground on March 2, 2018. The 25,000 square foot facility is expected to be completed in late summer 2018.
True Leaf is currently in the final stages of Health Canada’s Access to Cannabis for Medical Purposes Regulations (ACMPR) process.